img 09.09.2017

Scientists may soon trial a new class of drugs that specifically aim to delay or treat ageing. Writing in the Journal of American Geriatrics this week, doctors from the Mayo Clinic and Scripps Research Institute outline a set of new clinical trial paradigms that could be used to test the efficacy and safety of “Senolytics”, a new class of drugs that target mechanisms in the ageing process. ...

See source

Contact Form c